Strategies for CRISPR-based knock-ins in primary human B cells and lymphoma cell lines
{{output}}
Since its advent about ten years ago, the CRISPR-Cas9 system has been frequently used in biomedical applications. It has advanced various fields, and CRISPR-Cas9-based therapeutics have shown promising results in the treatment of specific hematological disease... ...
